Multicenter Phase Ii Trial To Investigate Safety And Efficacy Of An Adjuvant Therapy With Gemcitabine And Cetuximab In Patients With R0 Or R1 Resected Pancreatic Cancer.

JOURNAL OF CLINICAL ONCOLOGY(2011)

引用 1|浏览16
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要